The V Foundation Translational grant supports Dr. Wechsler-Reya's innovative research in identifying new targets and potential therapies for pediatric brain tumors.
Ben Izar, MD, PhD, joins this cohort with an award of $1.25 million to continue the transformative work in his lab to enhance T cell function in cancer immunotherapy.
The HICCC is pleased to announce a fifth Irving Cancer Drug Discovery Program (ICDDP) project, designed to help faculty accelerate cancer research discoveries.
New support from the MacMillan Family Foundation will address the urgent need for targeted interventions and community-driven solutions for disparities in cancer care.
HICCC members will present their innovative research and be recognized for their significant scientific contributions in the field of cancer research at the ASCO Annual meeting.
Lewis Silverman, MD will join the Department of Pediatrics as director of the Hope and Heroes Division of Pediatric Hematology, Oncology and Transplantation.
Aaron Viny, MD, MS has been awarded the Scholar Award, one of the most prestigious awards from the American Society for Hematology (ASH) that supports early career investigators.
Tannishtha Reya, PhD, is establishing the new Irving Cancer Drug Discovery Program, devoted to helping faculty accelerate research discoveries in their labs to the clinic.
HICCC Director Anil Rustgi, MD, is being honored for his major contributions in advancing the care of patients with digestive diseases through clinical or translational research.